Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Morphometric Quantification of Steatosis and Fibrosis in Metabolic Liver Disease Associated With Type 2 Diabetes
- Fourati O. , et al.
2. Double Graph Attention Network for predicting non-alcoholic fatty liver disease in patients with type 2 diabetes
- Chen T. , et al.
3. A Scoping Review of the Photographic Assessment of Donor Liver Steatosis in Transplantation Using Artificial Intelligence
- Kourounis G. , et al.
4. Recent Advances in the Application of Machine Learning Models in Metabolic Dysfunction–Associated Steatotic Liver Disease
- Yang F. , et al.
5. Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches
- Hernández-Almonacid P.G. , et al.
6. CONTEST: A generalization of ONEST to estimate sample size for predictive augmented intelligence method validation studies
- Olson B.K. , et al.
7. Deep learning for automated boundary detection and segmentation in organ donation photography
- Kourounis G. , et al.
8. Defining an NK Cell–enriched Rejection-like Phenotype in Liver Transplant Biopsies From the INTERLIVER Study
- Madill-Thomsen K.S. , et al.
9. Visual assessment of liver steatosis at retrieval predicts long term liver transplant outcomes in donation following circulatory death
- Ho N.X. , et al.
10. Limited use of FIB-4 index in patients under 65 years of age with type 2 diabetes mellitus
- Kim M. , et al.
12. Exposure–response modeling of liver fat imaging endpoints in non-alcoholic fatty liver disease populations administered ervogastat alone and co-administered with clesacostat
- Hughes J.H. , et al.
14. Classification of the Stages of Nonalcoholic Steatohepatitis via Federated General Visual Representation Learning
- Nergiz M. , et al.
15. Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis
- Ratziu V. , et al.
16. Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction–associated steatohepatitis
- Younossi Z.M. , et al.
17. This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol
- Fischer A.M. , et al.
18. Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques
- Hudson D. , et al.
19. Precision diagnostics in transplanted organs using microarray-assessed gene expression: concepts and technical methods of the Molecular Microscope® Diagnostic System (MMDx)
- Madill-Thomsen K.S. , et al.
21. An unsupervised transfer learning model based on convolutional auto encoder for non-alcoholic steatohepatitis activity scoring and fibrosis staging of liver histopathological images
- Karagoz M.A. , et al.
22. State of the art on the pathophysiology, diagnosis and treatment of non-alcoholic steatohepatitis (NASH)
- Grzych G. , et al.
23. Fatty Liver Disease
- Tiniakos D.G. , et al.